Doctor profile · Federal record
Dr. Rebecca Danforth, M.D.
Rheumatology Physician (CMS: Rheumatology) · Missoula, MT
- NPI 1164570172
- Accepts Medicare
- 24 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
500 W Broadway St
Missoula, MT 59802
(406) 721-5600
fax (406) 329-7547 - Mailing address
-
Po Box 7609
Missoula, MT 598077609
Credentials & registration
- NPI registered
- January 2007 — 19 yrs on file
- Profile last updated
- June 21, 2021
- Year of graduation
- 2002 — 24 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Montana #12452
- Medicaid
- MT #1164570172
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1164570172. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
36,900
Distinct HCPCS
10
Medicare allowed
$509,971
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3262 |
Injection, tocilizumab, 1 mg | 23,084 | 17 | $6 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 8,731 | 31 | $13 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 2,900 | 11 | $42 | |
J0897 |
Injection, denosumab, 1 mg | 1,080 | 12 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 335 | 192 | $128 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 174 | 88 | $179 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 163 | 78 | $64 | |
36415 |
Insertion of needle into vein for collection of blood sample | 78 | 45 | $8 | |
96372 |
Injection of drug or substance under skin or into muscle | 77 | 26 | $14 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 57 | 57 | $217 |
In context: peer comparison
Among 3 peers in Missoula Rheumatology Physician, average services per provider: 5,390. This provider delivers 6.8× the peer median.Open Payments
Industry payments received
All-time total
$620
Transactions
34
Manufacturers
6
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Pfizer INC. | 12 | $204.25 | |
| Abbvie INC. | 9 | $178.53 | |
| GlaxoSmithKline, LLC. | 6 | $117.42 | |
| Novartis Pharmaceuticals Corporation | 5 | $82.66 | |
| Sobi, INC | 1 | $19.25 | |
| Amgen INC. | 1 | $18.04 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,684
Patients
410
Total drug cost
$766,172
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 320 | 93 | $3,088 |
| Hydroxychloroquine Sulfate | Generic | 279 | 75 | $15,923 |
| Methotrexate (Methotrexate Sodium) | Brand | 241 | 50 | $7,313 |
| Meloxicam | Generic | 160 | 43 | $1,184 |
| Celecoxib | Generic | 137 | 42 | $4,781 |
| Sulfasalazine Dr (Sulfasalazine) | Brand | 108 | 23 | $5,007 |
| Leflunomide | Generic | 67 | 17 | $3,956 |
| Gabapentin | Generic | 59 | 0 | $1,215 |
| Allopurinol | Generic | 56 | 14 | $1,228 |
| Alendronate Sodium | Generic | 54 | 14 | $513 |
Hospital affiliations
Frequently asked questions
What is Dr. Rebecca Danforth's medical specialty?
Dr. Rebecca Danforth practices Rheumatology Physician in Missoula, MT.
Where does Dr. Rebecca Danforth practice?
Dr. Rebecca Danforth practices at 500 W Broadway St, Missoula, MT 59802. Office phone: 4067215600.
What is Dr. Rebecca Danforth's NPI?
Dr. Rebecca Danforth's National Provider Identifier (NPI) is 1164570172, issued by NPPES.
Does Dr. Rebecca Danforth accept Medicare assignment?
Yes. Dr. Rebecca Danforth accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Rebecca Danforth commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129). Source: CMS Medicare Physician & Other Practitioners file.